|
This wiki is closed in favour of the new wiki. Information shown is likely to be very out of date. |
Difference between revisions of "ExoGeni"
| Line 426: | Line 426: | ||
|- | |- | ||
|} | |} | ||
| + | |||
| + | ==Genetical Research Department== | ||
| + | |||
| + | '''Patented Products''': | ||
| + | |||
| + | ---- | ||
| + | |||
| + | |||
| + | '''Gene Theraphy''': Gene therapy is the insertion of genes into an individual's cells and tissues to alter the person's DNA. Gene therapy allows for the treatment of genetic disorders by replacing a defective mutant allele with a functional one using a carrier, also known as a vector, to deliver the therapeutic gene to the patient's target cells. Currently, the most common type of vectors are viruses that have been genetically altered to carry normal human DNA. | ||
Revision as of 22:59, 19 December 2010
| ExoGeni Corporation | |
| Origin |  Bretonia
|
| Alignment | Lawful/Corporation |
| Profile | |
| Date of founding | 802 A.S. |
| Date of dissolution | N/A A.S. |
| Founder(s) | Unknown |
| Current leader(s) | CEO Tiberius Maxwell TD Patrick Russ |
| Base of operations | Cambridge Research Station, Cambridge |
Description
ExoGeni is the leading genetical research department in Bretonia. In addition to funding the establishment of several bretonian colonies, ExoGeni has incidentally secured resource rights to worlds that may have undiscovered resources or remnants of alien technology, such as their newest colony on Planet Sprague. They are closely related to Cryer Pharmaceuticals. ExoGeni is known to be contracted by House militaries and privates alike for their bio-genetical implants. One of ExoGeni's subsidiaries is a private military contractor with a highly-trained security force capable of rescue, reconnaissance, and para-military operations. The corporation uses the force to secure and protect its assets and high profile employees.
History
The first founders of ExoGeni are still a shadow in the corporation's history, there are no documents about them, only that they assigned the control over the whole corporation to Professor Tiberius Maxwell. The Bretonia Police Authority had some relevant documents about ExoGeni, and those documents were dated to 802 A.S, two years after the Nomad War.
Even with all the possible documents related to ExoGeni, the whole deal on how the corporation was founded remains a mistery.
Job Opportunity
ExoGeni owned research and transport convoys increased their presence Sirius-wide since 802 A.S, their research convoys were seen in Omicron Theta, searching within the system's nebulas for artifacts. With some of the recent discoveries in xenoarcheology belonging entirely to them. Another important section of ExoGeni is their trading department, an independent section, not related to research operations, dealing in the transportation of materials like:
| Commodity | Error creating thumbnail: Unable to save thumbnail to destination
|
|
|
|
|
|
|
|
Error creating thumbnail: Unable to save thumbnail to destination
|
|---|---|---|---|---|---|---|---|---|---|
| Alien Organisms | 1 | Legal | RestrictedB1 | Legal | Legal | Legal | Legal | Legal - ImportG1 | Yes |
| Artifacts | 1 | Illegal | Illegal | RestrictedK1 | Illegal | Illegal | Legal | Legal - ImportG1 | |
| Beryllium | 1 | Legal | Legal | Legal | Legal | Legal | Legal | Legal | |
| Beryllium Ore | 1 | Legal | Legal | Legal | Legal | Legal | Legal | Legal | |
| Bio-Neural Processors | 1 | Legal | Legal | Legal | Legal | Legal | Legal | Legal | |
| Boron | 1 | Legal | Legal | Legal | Legal | Legal | Legal | Legal | |
| Cryocubes | 1 | Legal | Legal | Legal | Legal | Legal | Legal | Legal | |
| Deuterium | 1 | Legal | Legal | RestrictedK4 | Legal | Legal | Legal | Legal | |
| Fertilizers | 1 | Legal | Legal | Legal | Legal | Legal | Legal | Legal | |
| Food Rations | 1 | Legal | Legal | Legal | Legal | Legal | Legal | Legal | |
| Helium | 1 | Legal | Legal | Legal | Legal | Legal | Legal | Legal | |
| Human Organs | 1 | Illegal | RestrictedB1 | RestrictedK5 | Legal | Legal | Legal | Legal | Yes |
| Hydrocarbons | 1 | Legal | Legal | Legal | Legal | Legal | Legal | Legal | |
| Iridium | 1 | Legal | Legal | Legal | Legal | Legal | Legal | Legal | |
| Luxury Consumer Goods | 1 | Legal | Legal | Legal | Legal | Legal | Legal | Legal | |
| Mining Machinery | 1 | Legal | Legal | Legal | Legal | Legal | Legal | Legal | |
| Nano-capacitors | 1 | Legal | Legal | Legal | Legal | Legal | Legal | Legal | |
| Neon | 1 | Legal | Legal | Legal | Legal | Legal | Legal | Legal | |
| Optical Chips | 1 | Legal | Legal | Legal | Legal | Legal | Legal | Legal | |
| Optronics | 1 | Legal | Legal | RestrictedK4 | Legal | Legal | Legal | Legal | |
| Oxygen | 1 | Legal | Legal | Legal | Legal | Legal | Legal | Legal | |
| Pharmaceuticals | 1 | Legal | Legal | Legal | Legal | Legal | Legal | Legal | |
| Plutonium | 1 | Legal | RestrictedB1 | RestrictedK5 | Legal | Legal | Legal | Legal | Yes |
| Polymers | 1 | Legal | Legal | Legal | Legal | Legal | Legal | Legal | |
| Prometheum | 1 | Legal | Legal | Legal | Legal | Legal | Legal | Legal | Yes |
| Quantum Multiplexors | 1 | Legal | Legal | Legal | Legal | Legal | Legal | Legal - ImportG1 | |
| Robotic Components | 1 | Legal | Legal | Legal | Legal | Legal | Legal | Legal | |
| Scientists | 2 | Legal | Legal | Legal | Legal | Legal | Legal | Legal | |
| Spaceship Crew | 1 | Legal | Legal | Legal | Legal | Legal | Legal | Legal | |
| Super Alloy | 1 | Legal | Legal | Legal | Legal | Legal | Legal | Legal | |
| Superconductors | 1 | Legal | Legal | Legal | Legal | Legal | Legal | Legal | |
| Synth Paste | 1 | Legal | Legal | Legal | Legal | Legal | Legal | Legal | |
| Terraforming Gases | 1 | Legal | Legal | Legal | Legal | Legal | Legal | Legal | |
| Toxic Waste | 1 | Legal | Legal | Legal | Legal | Legal | Legal | Legal | |
| Water | 1 | Legal | Legal | Legal | Legal | Legal | Legal | Legal |
Genetical Research Department
Patented Products:
Gene Theraphy: Gene therapy is the insertion of genes into an individual's cells and tissues to alter the person's DNA. Gene therapy allows for the treatment of genetic disorders by replacing a defective mutant allele with a functional one using a carrier, also known as a vector, to deliver the therapeutic gene to the patient's target cells. Currently, the most common type of vectors are viruses that have been genetically altered to carry normal human DNA.
